Log in

MAXIMUS Stock Price, Forecast & Analysis (NYSE:MMS)

$76.22
-1.31 (-1.69 %)
(As of 11/20/2019 04:02 AM ET)
Today's Range
$73.68
Now: $76.22
$77.00
50-Day Range
$73.87
MA: $75.85
$77.99
52-Week Range
$60.00
Now: $76.22
$82.02
Volume843,886 shs
Average Volume326,582 shs
Market Capitalization$4.86 billion
P/E Ratio22.42
Dividend Yield1.44%
Beta0.82
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
CUSIP57793310
Phone703-251-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.39 billion
Cash Flow$4.38 per share
Book Value$16.91 per share

Profitability

Net Income$220.75 million

Miscellaneous

Employees18,600
Market Cap$4.86 billion
Next Earnings DateN/A
OptionableOptionable

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.


MAXIMUS (NYSE:MMS) Frequently Asked Questions

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS announced a quarterly dividend on Thursday, October 10th. Investors of record on Friday, November 15th will be given a dividend of $0.28 per share on Friday, November 29th. This represents a $1.12 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend is Thursday, November 14th. This is a boost from MAXIMUS's previous quarterly dividend of $0.25. View MAXIMUS's Dividend History.

How will MAXIMUS's stock buyback program work?

MAXIMUS declared that its board has authorized a share buyback plan on Monday, June 25th 2018, which permits the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 4.9% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's management believes its shares are undervalued.

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) released its quarterly earnings results on Tuesday, November, 19th. The health services provider reported $0.93 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.94 by $0.01. The health services provider earned $754.97 million during the quarter, compared to analyst estimates of $756.40 million. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The company's quarterly revenue was up 35.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.71 EPS. View MAXIMUS's Earnings History.

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS issued an update on its FY20 earnings guidance on Tuesday, November, 19th. The company provided earnings per share guidance of $3.95-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.07. The company issued revenue guidance of $3.15-3.30 billion, compared to the consensus revenue estimate of $3.17 billion.

What price target have analysts set for MMS?

2 analysts have issued 12 month price objectives for MAXIMUS's shares. Their forecasts range from $77.00 to $83.00. On average, they anticipate MAXIMUS's share price to reach $80.00 in the next year. This suggests a possible upside of 5.0% from the stock's current price. View Analyst Price Targets for MAXIMUS.

What is the consensus analysts' recommendation for MAXIMUS?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Has MAXIMUS been receiving favorable news coverage?

News headlines about MMS stock have trended very negative recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. MAXIMUS earned a news impact score of -3.9 on InfoTrie's scale. They also gave news coverage about the health services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for MAXIMUS.

Are investors shorting MAXIMUS?

MAXIMUS saw a increase in short interest in October. As of October 31st, there was short interest totalling 1,520,000 shares, an increase of 15.2% from the September 30th total of 1,320,000 shares. Based on an average trading volume of 334,200 shares, the short-interest ratio is currently 4.5 days. Currently, 2.4% of the company's stock are sold short. View MAXIMUS's Current Options Chain.

Who are some of MAXIMUS's key competitors?

What other stocks do shareholders of MAXIMUS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Adamis Pharmaceuticals (ADMP), AGNC Investment (AGNC), JetBlue Airways (JBLU), 3D Systems (DDD), New Oriental Education & Tech Grp (EDU), Lennar (LEN) and Macy's (M).

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the folowing people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Former Pres of Tax & Employer Services (Age 57)

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by many different of retail and institutional investors. Top institutional investors include Mondrian Investment Partners LTD (1.10%), Rice Hall James & Associates LLC (0.76%), Riverbridge Partners LLC (0.75%), Vaughan Nelson Investment Management L.P. (0.55%), Rhumbline Advisers (0.41%) and Russell Investments Group Ltd. (0.39%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

Which major investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL, Mondrian Investment Partners LTD, Meritage Portfolio Management, Glassman Wealth Services, Russell Investments Group Ltd., SG Americas Securities LLC, State of Tennessee Treasury Department and Mackay Shields LLC. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

Which major investors are buying MAXIMUS stock?

MMS stock was acquired by a variety of institutional investors in the last quarter, including Tygh Capital Management Inc., WBI Investments Inc., California Public Employees Retirement System, First Quadrant L P CA, Rhumbline Advisers, Bowling Portfolio Management LLC, Handelsbanken Fonder AB and Arabesque Asset Management Ltd. View Insider Buying and Selling for MAXIMUS.

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $76.22.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.86 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.View Additional Information About MAXIMUS.

What is MAXIMUS's official website?

The official website for MAXIMUS is http://www.maximus.com/.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]


MarketBeat Community Rating for MAXIMUS (NYSE MMS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  401 (Vote Outperform)
Underperform Votes:  398 (Vote Underperform)
Total Votes:  799
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel